NO20031873L - Syrenöytraliserende og laksativ tablett - Google Patents

Syrenöytraliserende og laksativ tablett

Info

Publication number: NO20031873L
Authority: NO; Norway
Prior art keywords: tablet; oxide particles; magnesium oxide; laxative; antacid
Prior art date: 2001-08-27

Application number

NO20031873A

Other languages

English (en)

Other versions

NO333440B1 (no

NO20031873D0 (no

Inventor

Mitsuhiro Sofue

Isamu Kawamura

Shigeo Yamao

Hideaki Baba

Shiro Horie

Yoko Abe

Hisae Sofue

Original Assignee

Kyowa Chem Ind Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-27

Filing date

2003-04-25

Publication date

2003-04-25

2003-04-25 Application filed by Kyowa Chem Ind Co Ltd filed Critical Kyowa Chem Ind Co Ltd

2003-04-25 Publication of NO20031873L publication Critical patent/NO20031873L/no

2003-04-25 Publication of NO20031873D0 publication Critical patent/NO20031873D0/no

2013-06-03 Publication of NO333440B1 publication Critical patent/NO333440B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Physiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20031873A 2001-08-27 2003-04-25 Syrenoytraliserende og laksativ tablett NO333440B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2001256421		2001-08-27
PCT/JP2002/006909 WO2003018034A1 (fr)	2001-08-27	2002-07-08	Comprimes antiacides et laxatifs

Publications (3)

Publication Number	Publication Date
NO20031873L true NO20031873L (no)	2003-04-25
NO20031873D0 NO20031873D0 (no)	2003-04-25
NO333440B1 NO333440B1 (no)	2013-06-03

Family

ID=19084237

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031873A NO333440B1 (no)	2001-08-27	2003-04-25	Syrenoytraliserende og laksativ tablett

Country Status (17)

Country	Link
US (1)	US7147868B2 (no)
EP (1)	EP1421944B1 (no)
KR (3)	KR20080099353A (no)
CN (1)	CN1262278C (no)
AT (1)	ATE380546T1 (no)
AU (1)	AU2002318630B2 (no)
CA (1)	CA2424554C (no)
DE (1)	DE60224056T2 (no)
DK (1)	DK1421944T3 (no)
ES (1)	ES2296960T3 (no)
MX (1)	MXPA03003292A (no)
MY (1)	MY134676A (no)
NO (1)	NO333440B1 (no)
PT (1)	PT1421944E (no)
RU (1)	RU2284189C2 (no)
TW (1)	TWI331044B (no)
WO (1)	WO2003018034A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9720061D0 (en) *	1997-09-19	1997-11-19	Crosfield Joseph & Sons	Metal compounds as phosphate binders
US20050220865A1 (en) *	2004-04-02	2005-10-06	Koleng John J	Compressed composition comprising magnesium salt
US20060165759A1 (en) *	2005-01-27	2006-07-27	Warner-Lambert Company Llc	Antacid lozenge containing micronized particles
MY157620A (en) *	2006-01-31	2016-06-30	Cytochroma Dev Inc	A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) *	2007-07-27	2007-09-05	Ineos Healthcare Ltd	Use
GB0720220D0 (en) *	2007-10-16	2007-11-28	Ineos Healthcare Ltd	Compound
US20100260852A1 (en) *	2007-10-29	2010-10-14	Keiko Katsuki	Laxative agent
RU2519222C2 (ru) *	2009-02-25	2014-06-10	Киова Кемикал Индастри Ко., Лтд.	Гранулы оксида магния
JP5564040B2 (ja)	2009-04-22	2014-07-30	協和化学工業株式会社	錠剤
GB0913525D0 (en)	2009-08-03	2009-09-16	Ineos Healthcare Ltd	Method
WO2011030659A1 (ja) *	2009-09-08	2011-03-17	協和化学工業株式会社	制酸・緩下用錠剤
GB201001779D0 (en)	2010-02-04	2010-03-24	Ineos Healthcare Ltd	Composition
CN102283861A (zh) *	2010-06-17	2011-12-21	杭州赛利药物研究所有限公司	氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法
PL395069A1 (pl) *	2011-05-31	2012-12-03	Warszawski Uniwersytet Medyczny	Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
JP2014224080A (ja) *	2013-05-17	2014-12-04	協和化学工業株式会社	大腸の検査または手術のための処置剤
CN106029103B (zh)	2014-02-25	2021-12-31	神岛化学工业株式会社	医药用或食品添加用的氧化镁颗粒
CN108686222B (zh) *	2018-06-13	2021-03-19	合肥合源药业有限公司	瑞舒伐他汀钙组合物的制备方法
TWI724629B (zh)	2018-11-16	2021-04-11	日商協和化學工業股份有限公司	緩瀉用錠劑
CN111281855B (zh) *	2020-03-23	2021-09-24	乐普制药科技有限公司	一种雷贝拉唑肠溶片及其制备方法
CN115487160A (zh) *	2022-09-27	2022-12-20	威海百合生物技术股份有限公司	一种氧化镁片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988000051A1 (en)	1986-06-24	1988-01-14	Racz Istvan	Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability
JP2731854B2 (ja) *	1989-02-10	1998-03-25	協和化学工業株式会社	高耐水和性、高流動性酸化マグネシウムの製造方法
DE3937455A1 (de) *	1989-11-10	1991-05-16	Nordmark Arzneimittel Gmbh	Antacidatabletten
IT1250701B (it)	1991-07-24	1995-04-21	Angelini Francesco Ist Ricerca	Composizione farmaceutica solida per uso orale a base di dapiprazolo
JP2711614B2 (ja) *	1992-06-10	1998-02-10	新日本製鐵株式会社	皮膜特性及び磁気特性の優れた方向性電磁鋼板の製造方法
SE9302395D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	New pharmaceutical formulation
JPH0940561A (ja) *	1995-08-02	1997-02-10	Fujitsukusu Kk	瀉下剤
JPH10120416A (ja) *	1996-10-17	1998-05-12	Kyowa Chem Ind Co Ltd	水懸濁用水酸化マグネシウム粉末
JP2000001428A (ja) *	1998-04-16	2000-01-07	Nippon Shinyaku Co Ltd	錠剤及び製造法
RU2189560C2 (ru) *	1998-08-24	2002-09-20	Товарищество с ограниченной ответственностью "Научно-производственный центр "Квазар-ВВ"	Квазар-способ взрывного разрушения крупногабаритных объектов и квазар-заряды для его осуществления
JP2001048792A (ja) *	1998-11-26	2001-02-20	Fujix Kk	瀉下剤

2002
- 2002-07-08 CN CNB028027949A patent/CN1262278C/zh not_active Expired - Fee Related
- 2002-07-08 DE DE60224056T patent/DE60224056T2/de not_active Expired - Lifetime
- 2002-07-08 DK DK02745874T patent/DK1421944T3/da active
- 2002-07-08 MX MXPA03003292A patent/MXPA03003292A/es active IP Right Grant
- 2002-07-08 KR KR1020087025839A patent/KR20080099353A/ko not_active Ceased
- 2002-07-08 RU RU2003112224/15A patent/RU2284189C2/ru not_active IP Right Cessation
- 2002-07-08 US US10/380,407 patent/US7147868B2/en not_active Expired - Fee Related
- 2002-07-08 AU AU2002318630A patent/AU2002318630B2/en not_active Ceased
- 2002-07-08 ES ES02745874T patent/ES2296960T3/es not_active Expired - Lifetime
- 2002-07-08 KR KR1020037003649A patent/KR100972773B1/ko not_active Expired - Fee Related
- 2002-07-08 AT AT02745874T patent/ATE380546T1/de active
- 2002-07-08 WO PCT/JP2002/006909 patent/WO2003018034A1/ja not_active Ceased
- 2002-07-08 KR KR1020097009958A patent/KR20090065552A/ko not_active Ceased
- 2002-07-08 PT PT02745874T patent/PT1421944E/pt unknown
- 2002-07-08 CA CA002424554A patent/CA2424554C/en not_active Expired - Fee Related
- 2002-07-08 EP EP02745874A patent/EP1421944B1/en not_active Expired - Lifetime
- 2002-07-16 TW TW091115825A patent/TWI331044B/zh not_active IP Right Cessation
- 2002-08-26 MY MYPI20023153A patent/MY134676A/en unknown
2003
- 2003-04-25 NO NO20031873A patent/NO333440B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE60224056T2 (de)	2008-12-04
CA2424554A1 (en)	2003-03-06
WO2003018034A1 (fr)	2003-03-06
ES2296960T3 (es)	2008-05-01
KR20090065552A (ko)	2009-06-22
KR20080099353A (ko)	2008-11-12
EP1421944A4 (en)	2005-08-31
US7147868B2 (en)	2006-12-12
MXPA03003292A (es)	2004-12-13
MY134676A (en)	2007-12-31
EP1421944A1 (en)	2004-05-26
KR20040044385A (ko)	2004-05-28
PT1421944E (pt)	2008-01-03
TWI331044B (en)	2010-10-01
HK1061641A1 (zh)	2004-09-30
CN1262278C (zh)	2006-07-05
EP1421944B1 (en)	2007-12-12
NO333440B1 (no)	2013-06-03
KR100972773B1 (ko)	2010-07-30
NO20031873D0 (no)	2003-04-25
DE60224056D1 (de)	2008-01-24
US20040022872A1 (en)	2004-02-05
AU2002318630B2 (en)	2007-05-17
ATE380546T1 (de)	2007-12-15
CA2424554C (en)	2009-08-18
CN1473049A (zh)	2004-02-04
DK1421944T3 (da)	2008-03-31
RU2284189C2 (ru)	2006-09-27

Publication	Publication Date	Title
NO20031873L (no)	2003-04-25	Syrenöytraliserende og laksativ tablett
HUP0003897A2 (hu)	2001-08-28	Pezsgő sav-bázis párt tartalmazó gyógyászati kompozíciók
GR3031135T3 (en)	1999-12-31	Compositions containing S(+)-Ibuprofen.
CN1071116C (zh)	2001-09-19	哌罗克西丁片剂及其制备方法
EA024980B1 (ru)	2016-11-30	Лекарственные формы, содержащие основание прасугреля или его фармацевтически приемлемые соли присоединения кислоты, и способы их приготовления
UA63993C2 (uk)	2004-02-16	Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
HRP20040829A2 (en)	2006-07-31	Formulations of atorvastatin stabilized with alkali metal additions
AU5677099A (en)	2000-03-27	New solid dose form of nanoparticulate naproxen
RU2004118709A (ru)	2005-04-20	Составы, содержащие азитромицин, поддающиеся прямому прессованию
NZ336789A (en)	2000-11-24	Use of methacrylic acid copolymer type C in the manufacture of tablets
NZ533060A (en)	2006-03-31	Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
UA41346C2 (uk)	2001-09-17	Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
MD872G2 (ro)	1998-08-31	Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
BRPI0410116A (pt)	2006-05-23	tablete de cuidado oral
ATE195073T1 (de)	2000-08-15	Feste pharmazeutische zubereitung mit (s)-2-(4- isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff
RU2003112224A (ru)	2004-08-27	Антацидная и слабительная таблетка
MY127350A (en)	2006-11-30	Flash-melt oral dose formulations
ATE329582T1 (de)	2006-07-15	Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
RU2006104009A (ru)	2006-06-27	Фармацевтическая препаративная форма
ES2061880T3 (es)	1994-12-16	Composicion y metodo de granulacion.
DE69715301D1 (de)	2002-10-17	Neue Diacerhein Formulierungen, erhalten durch Einschluss des Wirkstoffs in Polysaccharidhydrogele
GB2362103B (en)	2002-10-16	Pharmaceutical compositions including alginates
ES2174734A1 (es)	2002-11-01	Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
JP4805537B2 (ja)	2011-11-02	相乗効果のある賦形剤組成物
WO2003013441A3 (en)	2003-10-30	Levothyroxine compositions and methods

Legal Events

Date	Code	Title	Description
2018-02-26	MM1K	Lapsed by not paying the annual fees